Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(4 Publications)
Rabbit Recombinant Monoclonal Coxsackie Adenovirus Receptor/hCAR antibody. Suitable for IP, Flow Cyt, WB, ICC/IF and reacts with Human samples. Cited in 4 publications.
View Alternative Names
CAR, CXADR, Coxsackievirus and adenovirus receptor, hCAR, CVB3-binding protein, Coxsackievirus B-adenovirus receptor, HCVADR
- Flow Cyt
Unknown
Flow Cytometry - Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] (AB272711)
Flow cytometric analysis of K-562 (Human chronic myelogenous leukemia lymphoblast, Left) / HepG2 (Human hepatocellular carcinoma epithelial cell, Right) cells labelling Coxsackie Adenovirus Receptor/hCAR with ab272711 at 1/500 dilution (0.1ug) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) at 1/2000 dilution was used as the secondary antibody.
Negative control : K-562 (PMID : 30450519)Gated on viable cells.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] (AB272711)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HepG2 cells labelling Coxsackie Adenovirus Receptor/hCAR with ab272711 at 1/50 dilution, followed by ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing membranous and cytoplasmic staining in HepG2 cell line. Negative control : K562 (PMID : 30450519) ab195887 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 488) was used to counterstain tubulin at 1/200 dilution (Red). The Nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Secondary antibody is ab150077 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) at 1/1000 dilution.
- IP
Unknown
Immunoprecipitation - Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] (AB272711)
Coxsackie Adenovirus Receptor/hCAR was immunoprecipitated from 0.35 mg HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate with ab272711 at 1/30 dilution (2ug in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab272711 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP)(ab131366) was used at 1/5000 dilution.
Lane 1 : HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate 10 ug
Lane 2 : ab272711 IP in HepG2 whole cell lysate
Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab272711 in HepG2 whole cell lysate
Blocking and dilution buffer and concentration : 5% NFDM/TBST.
Exposure time : 102 seconds
All lanes:
Immunoprecipitation - Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] (ab272711)
Predicted band size: 40 kDa
false
- WB
Lab
Western blot - Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] (AB272711)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile observed is consistent with what has been described in the literature, differently mobilized bands of coxsackie adenovirus receptor are attributed to different levels of glycosylation and the presence of isoforms. (PMID : 28074864, 11734628)
Negative control : PC-3 (PMID : 28074864) and K-562 (PMID : 30450519).
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 3 minutes
All lanes:
Western blot - Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] (ab272711) at 1/1000 dilution
Lane 1:
LoVo (human colorectal adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
HepG2 (human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3:
PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
HaCaT (human skin keratinocyte) whole cell lysate at 20 µg
Lane 5:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Lane 6:
BxPC-3 (human pancreas adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 40 kDa
Observed band size: 35-50 kDa
false
- WB
Lab
Western blot - Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] (AB272711)
Blocking and diluting buffer and concentration : 5% NFDM/TBST
The expression profile observed is consistent with what has been described in the literature (PMID : 28074864, 11734628)
This blot was developed using a higher sensitivity ECL substrate.
Exposure time : 125 seconds
All lanes:
Western blot - Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] (ab272711) at 1/1000 dilution
Lane 1:
Human brain tissue lysate at 20 µg
Lane 2:
Human liver tissue lysate at 20 µg
Lane 3:
Human heart tissue lysate at 20 µg
Secondary
All lanes:
VeriBlot for IP secondary antibody(HRP)(<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/1000 dilution
Predicted band size: 40 kDa
Observed band size: 35 kDa,45 kDa
false
Related conjugates and formulations (1)
-
Anti-Coxsackie Adenovirus Receptor/hCAR antibody [EPR23305-44] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (4)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 15:10889 PubMed39738070
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology research 12:1640-1654 PubMed39093821
2024
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 19:e1011090 PubMed36634130
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 12:640521 PubMed33790796
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com